Hypertension, Portal: all 345 studies
Page 3 of 4. Open to participants first (110), then studies with results posted, then the rest; newest registration first within each.
- Primary Prophylaxis for Variceal Bleed in Biliary AtresiaStatus unknownNCT04494763Not applicable
- Portal Pressure Effects of Phlebotomy Combined to Vasopressin Use in Cirrhotic Patients Undergoing Liver TransplantationCompletedNCT04472312
- The Precise Selection of Stent Diameter for Portal Hypertension Patients With TIPSStatus unknownNCT04421118
- Anticoagulation Therapy After Splenectomy in Cirrhosis PatientCompletedNCT04397289Phase 1/2
- Hemodynamic Profile of Terlipressin and Octreotide in Patients With Cirrhosis and Portal Hypertension. A Randomised, Single Blinded Clinical Trial.Status unknownNCT04353193Phase 4
- Comparing Ascites Relief In Two Standard Treatments: Large Volume Paracentesis Vs. Early Tips Using Viatorr Controlled Expansion StentsCompletedNCT04315571Not applicable
- ADAMTS-13 and Von Willebrand Factor Levels and Activities in Children With Cirrhosis and/or Portal HypertensionCompletedNCT04267406
- Dual Arterial Phase Liver CT in Patients With Suspected Portal HypertensionStatus unknownNCT04195971Not applicable
- EGD vs EUS in Diagnosing Portal Hypertension in Cirrhotic Patients.Status unknownNCT04191369Not applicable
- Portal Hypertension in Non-alcoholic Fatty Liver Disease: Association With Cardiovascular Risk and Identification of Non-invasive Biomarkers (THESIS)Status unknownNCT04191044
- Non-invasive Method for Predicting the Presence of Gastroesophageal Varices in Patients With CirrhosisStatus unknownNCT04123509
- Perioperative Care of HVPG Measurement (CHESS1904): An International Multicenter SurveyCompletedNCT04121520
- Somatostatin in Living Donor Liver TransplantationStatus unknownNCT04107428Phase 4
- TIPS Plus Transvenous Obliteration for Gastric VaricesCompletedNCT04044248
- The Role of Somatostatin in the Hemodynamics of the Hepatic Circulation in Patients Undergoing Liver ResectionStatus unknownNCT04010669Phase 3
- Apixaban for Intrahepatic Non Cirrhotic Portal HypertensionActive, not recruitingNCT04007289Phase 3
- Effects of a Novel Physical Exercise Program in Patients With Cirrhosis (the LFN-exercise Protocol)CompletedNCT03932552Not applicable
- A Study Evaluating the Utility of Ambrisentan in Lowering Portal Pressure in Patients With Liver CirrhosisTerminatedNCT03827200Phase 2
- The Influence of Post-transjugular Intrahepatic Portosystemic Shunt Hepatic EncephalopathyStatus unknownNCT03825848Not applicable
- HVPG-guided Laparoscopic Versus Endoscopic Therapy for Variceal Rebleeding in Portal Hypertension: A Multicenter Randomized Controlled Trial (CHESS1803)Status unknownNCT03783065Not applicable
- Non-invasive Evaluation of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease by Assessment of Spleen Stiffness Using VCTE by FibroScan.CompletedNCT03778411
- MR-based Models for Clinically Significant Portal Hypertension in Cirrhosis (CHESS1802)CompletedNCT03766880Not applicable
- Accuracy of Magnetically Maneuvered Capsule Endoscopy for Detection of EGV in Patients With CirrhosisCompletedNCT03748563Not applicable
- Carvedilol for Prevention of Esophageal Varices ProgressionStatus unknownNCT03736265Not applicable
- Propranolol, Carvedilol and Rosuvastatin in the Prevention of Variceal Bleeding in Cirrhotic Portal HypertensionStatus unknownNCT03720067Phase 2/3
- Serum Biomarkers for Portal Hypertension in Cirrhosis (Pan-CHESS1802)Status unknownNCT03713606
- The Clinical Significance of Portal Hypertension After Cardiac Surgery: a Multicenter Prospective Observational StudyCompletedNCT03656263
- Non-invasive Evaluation Program for TIPS and Follow Up NetworkCompletedNCT03628807
- Splenic Embolization for Portal HypertensionWithdrawnNCT03532750Not applicable
- MRI to Assess the Effect of Terlipressin in Patients With Acute Hepatorenal Syndrome (HRS-AKI)CompletedNCT03483272
- Establishment and Assessment of the HVPG Using Biofluid Mechanics (HVPGBFM)Status unknownNCT03470389Not applicable
- Outcome After TIPSCompletedNCT03459378
- Feasibility And Safety Of Transjugular Intrahepatic Portosystemic Shunt (TIPS) Creation Using A Radiofrequency GuidewireCompletedNCT03451149Not applicable
- Hemodynamic Alterations in Liver Cirrhosis Validated by Non-invasive MR Compared to Invasive AssessmentCompletedNCT03443934
- MRI to Assess the Effect of Non-selective Beta-blocker in Patients With CirrhosisCompletedNCT03438916
- Assessment of Portal Hypertension With Multiparametric MRICompletedNCT03436550
- Ultrasound Elastography Assessment of Spleen and Liver Stiffness Before and After Transjugular Intrahepatic Portosystemic Shunt (TIPS) ProcedureCompletedNCT03427164Not applicable
- Spleen-ARFI-assisted-Portal-Hypertension-Evaluation-Study (SAPHES)Status unknownNCT03315767Not applicable
- Noninvasive Diagnostic Platform for Liver Fibrosis and Portal HypertensionStatus unknownNCT03277651
- Role of RDW as Anon Invasive Index for Predicting Liver Cell Failure and Portal Hypertension in Cirrhotic PatientStatus unknownNCT03242135
- WFA+M2BP in Evaluation of Portal Hypertension and Clinical Outcome in Patients With Liver CirrhosisStatus unknownNCT03195634
- Virtual Imaging-based Early Portal Pressure Gradient (vePPG) (CHESS1702)WithdrawnNCT03177499Not applicable
- The Use of Propranolol for the Prevention of Worsening of Esophageal Varices in Patients With Isolated Gastric VaricesStatus unknownNCT03171805Not applicable
- Low Molecular Weight Heparin for the Prevention of Early TIPS DysfunctionStatus unknownNCT03171727Not applicable
- Utility of EUS-elastography to Predict Portal HypertensionCompletedNCT03155282
- Radiomics Signature of Hepatic Venous Pressure Gradient (rHVPG) With CT Angiography (CHESS1701)CompletedNCT03138915Not applicable
- Can MRI Evaluate Beta-blocker Response in Portal Hypertension?Status unknownNCT03114813
- 8mm-TIPS Versus Endoscopic Variceal Ligation (EVL) Plus Propranolol for Prevention of Variceal Rebleeding in Patients With Child A CirrhosisStatus unknownNCT03094234Not applicable
- Viatorr CX Case-control Study for Complications of Portal HypertensionCompletedNCT03083925
- Role of SWE-change After TIPS in the Prediction of Prognosis After TIPSCompletedNCT03072615
- A Novel Approach for Transjugular Intrahepatic Portocaval Shunt Creation Using Real-time Three Dimensional RoadmapCompletedNCT03031366Not applicable
- Evaluation Of The Portal Pressure By Doppler Ultrasound In Cirrhotic Patients Before And After SimvastatinCompletedNCT02994485Phase 4
- Doppler Ultrasound Hepatic Vein Waveform as a Non-invasive Tool in the Assessment of Severity of Portal HypertensionStatus unknownNCT02975323Phase 3
- Treatment of Moderate and Severe Cirrhotic Portal Hypertension Due to HBV With Fuzheng Huayu and EntecavirStatus unknownNCT02945982Phase 4
- Treatment of Low-grade Cirrhotic Portal Hypertension Due to Hepatitis B Virus With Fuzheng Huayu and EntecavirStatus unknownNCT02945956Phase 4
- Early Precise Diagnosis and Intervention of CPT Based on a Noninvasive 3D-vHPSStatus unknownNCT02925975Phase 4
- FibroScan™ in Pediatric Cholestatic Liver Disease (FORCE)CompletedNCT02922751
- Spironolactone on Fibrosis Progrssion-Portal Hypertension(FP-PH)in CirrhosisCompletedNCT02907749Phase 4
- Microparticles in Cirrhosis and Portal HypertensionCompletedNCT02859610Not applicable
- Portal Hypertension and Systemic Endothelial FunctionStatus unknownNCT02850692Not applicable
- Virtual Hepatic Venous Pressure Gradient (vHVPG) With CT Angiography (CHESS1601)CompletedNCT02842697Not applicable
- The Treatment of Hepatocirrhosis and Portal HypertensionCompletedNCT02778425Not applicable
- Evaluation of Gastroesophageal Varices by Transnasal Endoscopy.Status unknownNCT02767206
- The International Imaging Registry in Liver Cirrhosis (BAVENO-VI SPSS GROUP).Status unknownNCT02692430
- Serelaxin To Lower Portal PressureCompletedNCT02669875Phase 2
- Correlation of Liver and Spleen Stiffness by RT-2D-SWE and Severity of Portal Hypertension by HVPGStatus unknownNCT02653846
- Risk Factors for Variceal Bleeding in Egyptian Patients With Non-Cirrhotic Portal HypertensionCompletedNCT02635815
- Correlation of Platelets Count With Endoscopic Findings in a Cohort of Egyptian Patients With Liver CirrhosisStatus unknownNCT02621372
- Macrophages, Portal Hypertension, and Liver Function During AbbVie Treatment of Chronic Hepatitis CCompletedNCT02526641
- Effect of Administration of Rifaximin on the Portal Pressure of Patients With Liver Cirrhosis and Esophageal VaricesStatus unknownNCT02508623Phase 3
- Surrogate Markers of Portal PressureCompletedNCT02508298Not applicable
- Percutaneous Transhepatic Intrahepatic Portosystemic Shunt for Treatment of Portal Vein Occlusion With Symptomatic Portal Hypertension After SplenectomyStatus unknownNCT02505152Not applicable
- Cavernous Transformation of Portal Vein： Etiology, Diagnosis, Management and PrognosisStatus unknownNCT02505113
- Interventional Radiology for the Treatment of Symptomatic Portal Hypertension in Patients With Cavernous Transformation of Portal VeinStatus unknownNCT02504034Not applicable
- 3D CT Guidance for Transjugular Intrahepatic Portosystemic Shunt CreationStatus unknownNCT02480426Not applicable
- 8mm-TIPS Versus Endoscopic Variceal Ligation (EVL) Plus Propranolol for Prevention of Variceal RebleedingCompletedNCT02477384Not applicable
- To Compare the Efficacy and Safety of Carvedilol With or Without Simvastatin in Patients With Portal Hypertension and Esophageal Varices.CompletedNCT02465645Not applicable
- Transient Elastography to Assess Liver Fibrosis and Portal Hypertension in HCV Cirrhotic Patients Treated With New Antiviral Drugs (SPLEEN-C)CompletedNCT02439567Not applicable
- TIPS in Fundal Variceal Bleeding (the TFB Study)Status unknownNCT02364297Not applicable
- A Pilot Study: Defining Peripheral Endothelial Function in Portal Hypertensive Cirrhotic PatientsWithdrawnNCT02356250
- Effect of Taurine on Portal Hemodynamics in Patients With Advanced Liver CirrhosisCompletedNCT02344719Phase 4
- Follow-up Study of Complications of Acute PancreatitisStatus unknownNCT02305914
- Predictive Factors and Outcome of Esophageal Ulcers After Endoscopic Treatment of Esophageal VaricesStatus unknownNCT02256046Not applicable
- Laparoscopic Versus Open Devascularization for Portal Hypertension, a Randomized Controlled TrialStatus unknownNCT02178319Not applicable
- Portal Hypertension and Liver Resection in Patients With Hepatocellular CarcinomaStatus unknownNCT02145013
- Simvastatin Effect on Portal HypertensionCompletedNCT02134626Phase 3
- Carvedilol vs Band Ligation vs Combination Therapy for Primary Prophylaxis of Variceal BleedingWithdrawnNCT02066649Phase 3
- Evaluation of 3D Overlay During Transjugular Intrahepatic Portosystemic Shunt (TIPS) ProcedureCompletedNCT02053571Not applicable
- 3D Sonographic Measurement of Volumetric Flow in Transjugular Intrahepatic Porto-Systemic ShuntsCompletedNCT02046473Not applicable
- Treatment Schistosomal Portal Hypertension: Efficacy of Endoscopy or SurgeryCompletedNCT01931826Not applicable
- Injection of Cyanoacrylate+Lipiodol vs Cyanoacrylate+Lauromacrogol in Gastric VaricesCompletedNCT01923064Not applicable
- Rifaximin and Propranolol Combination Therapy Versus Propranolol Monotherapy in Cirrhotic PatientsStatus unknownNCT01897051Phase 2/3
- MBT Versus HVPG in Identifying Responders to Portal Hypertension TherapyCompletedNCT01851252Phase 1
- Quality of Life and Nutritional Improvements in Cirrhotic PatientsTerminatedNCT01842113Phase 4
- Screening for Asymptomatic Portal Vein Thrombosis and Portal Hypertension in Patients With Philadelphia Negative Myeloproliferative NeoplasmsCompletedNCT01816256Not applicable
- Comparative Analysis of Different Tests to Evaluate Prognosis of Patients on Liver Transplant Waiting ListCompletedNCT01774617
- MRI in Portal HypertensionStatus unknownNCT01756859
- HVPG for Rebleeding Risk StratificationCompletedNCT01751191
- Non-invasive Diagnosis of Portal Hypertension With Acoustic Radiation Force Impulse (ARFI)CompletedNCT01644656Not applicable
- Optimal Treatment on Hepatocellular Carcinoma (HCC) With Cirrhotic Portal HypertensionCompletedNCT01642446Not applicable